Breast cancer patients who interrupted endocrine therapy to pursue pregnancy did not have worse ...

Dr Cristina Saura speaks to ecancer as part of SABCS 2022 about the results of the POSITIVE trial.

She states the primary endpoint of the trial was a breast cancer free interval for patients.

Dr Saura explains the results showed breast cancer patients who interrupted endocrine therapy to pursue pregnancy did not have worse short-term recurrence rates..

• categoría